This article has been updated from a previous version to include comments made by Natera executives during an earnings call.

NEW YORK (GenomeWeb) – Natera reported after the close of the market Tuesday that its fourth quarter revenues grew about 9 percent year over year as the company fell short of Wall Street expectations on both the top and bottom lines.

For the three months ended Dec. 31, 2017, Natera tallied revenues of $53.8 million compared to $49.3 million a year ago. Analysts on average had expected Q4 revenues of $57.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.